Related Experiment Video
Updated: May 8, 2026
Cell Death Associated with Abnormal Mitosis Observed by Confocal Imaging in Live Cancer Cells
Published on: August 21, 2013
PARP inhibitors are not all equal
1Department of Neurosurgery; Massey Cancer Center; Virginia Commonwealth University; Richmond, VA USA.
Abstract:
To many investigators PARP1 is simply a substrate for caspase 3, and whose cleavage is thought indicative of apoptosis. However, in reality PARP1 plays a major role in the biology of the cell cycle and DNA repair. (1)(,) (2) PARP1 binds to damaged DNA where it becomes enzymatically activated and ADP ribosylates itself and other proteins. PARP facilitates DNA repair complex formation, e.g., with BRCA1/2, and the activation of the cell cycle regulatory enzymes ATM and ATR. (2) PARP inhibitors as a single agent have only shown any degree of efficacy in breast and ovarian cancer patients who lack BRCA1/2 function. (3)(,) (4) The present studies examined PARP1 inhibitor biology in a range of triple negative and non-triple negative breast cancer cell lines.
Insights
Poly (ADP-ribose) polymerase 1 (PARP1) is crucial for DNA repair and cell cycle regulation, not just apoptosis. PARP1 inhibitors show potential in specific breast cancer subtypes, warranting further investigation.
Area of Science:
- Molecular Biology
- Oncology
- Biochemistry
Background:
- Poly (ADP-ribose) polymerase 1 (PARP1) is traditionally viewed as a caspase 3 substrate, indicating apoptosis.
- However, PARP1 is fundamentally involved in DNA repair and cell cycle regulation.
- PARP1 activation by damaged DNA facilitates DNA repair complex formation and cell cycle checkpoint activation.
Purpose of the Study:
- To investigate the biological role and therapeutic potential of PARP1 inhibitors.
- To examine PARP1 inhibitor efficacy across diverse breast cancer cell lines, including triple-negative subtypes.
Main Methods:
- Cell line studies involving a range of triple-negative and non-triple-negative breast cancer models.
- Analysis of PARP1 inhibitor biology within these cellular contexts.
Main Results:
- PARP1 plays a significant role in DNA repair and cell cycle progression.
- PARP inhibitors have demonstrated limited efficacy as single agents, particularly in patients with functional BRCA1/2.
Conclusions:
- PARP1's function extends beyond apoptosis, highlighting its importance in DNA repair and cell cycle control.
- Further research into PARP1 inhibitor mechanisms and applications in breast cancer is warranted, especially in specific patient populations.
Related Concept Videos
01:02Long-patch Base Excision Repair
01:27Principles of Pharmacogenetics: Types of Genetic Variants
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
01:28Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
01:19Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...